angiotensin ii, des-phe(8)- has been researched along with gentamicin in 2 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Fattah, MM; Elgendy, ANAM; Mohamed, WR | 1 |
| de Castro, CH; de Souza Lino Junior, R; Dos Santos, RAS; Dutra, JBR; Ferreira, PM; Pacheco, LF; Ulhoa, CJ | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and gentamicin
| Article | Year |
|---|---|
Xanthenone, ACE2 activator, counteracted gentamicin-induced nephrotoxicity in rats: Impact on oxidative stress and ACE2/Ang-(1-7) signaling.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Gentamicins; Interleukins; Male; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Xanthones | 2021 |
Oral Treatment with Angiotensin-(1-7) Attenuates the Kidney Injury Induced by Gentamicin in Wistar Rats.
Topics: Acute Kidney Injury; Administration, Oral; Angiotensin I; Animals; Drug Evaluation; Gentamicins; Male; Peptide Fragments; Rats; Rats, Wistar | 2021 |